Dec 20, 2025
What large ongoing randomized trials are testing neuromodulation (TMS/tACS) or anti‑tau antibodies in MCI and when will their results be reported?
Large, randomized anti‑tau antibody trials enrolling people with mild cognitive impairment (MCI) are actively underway and have staggered completion dates through 2027–2028, while the reporting provid...